Covered recipient · General Payments record
JERROD D JUSTICE
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2019–2024
$2,359.84
- Reported across 74 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $442.33 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $164.55 | 3 |
| ABBVIE INC. | $96.35 | 5 |
| Astellas Pharma US Inc | $49.43 | 3 |
| Biogen, Inc. | $44.50 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $30.50 | 2 |
| Amgen Inc. | $21.25 | 1 |
| Organon LLC | $21.16 | 1 |
| Sumitomo Pharma America, Inc. | $14.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.83 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104016542 | CMS |
| ABBVIE INC. | $23.27 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104016544 | CMS |
| ABBVIE INC. | $15.59 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104016546 | CMS |
| ABBVIE INC. | $17.74 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104016548 | CMS |
| ABBVIE INC. | $16.92 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104016550 | CMS |
| Amgen Inc. | $21.25 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111612263 | CMS |
| Astellas Pharma US Inc | $15.35 | 01/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139309454 | CMS |
| Astellas Pharma US Inc | $19.35 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139326552 | CMS |
| Astellas Pharma US Inc | $14.73 | 12/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139445438 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $13.31 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086218431 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $17.19 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086135453 | CMS |
| Biogen, Inc. | $17.20 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104810391 | CMS |
| Biogen, Inc. | $27.30 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104838318 | CMS |
| Organon Llc | $21.16 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136206003 | CMS |
| PFIZER INC. | $22.34 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131179110 | CMS |
| PFIZER INC. | $116.91 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131480080 | CMS |
| PFIZER INC. | $25.30 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131748986 | CMS |
| Sumitomo Pharma America, Inc. | $14.59 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148870973 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.